The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated efficacy and safety of avelumab in metastatic urothelial carcinoma (mUC): Pooled analysis from 2 cohorts of the phase 1b Javelin solid tumor study.
 
Andrea B. Apolo
No Relationships to Disclose
 
John Allan Ellerton
No Relationships to Disclose
 
Jeffrey R. Infante
Research Funding - Aileron Therapeutics (Inst); ARMO BioSciences (Inst); AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Calithera Biosciences (Inst); Celldex (Inst); Celldex (Inst); eFFECTOR Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Janssen Oncology (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Phosplatin Therapeutics (Inst); Roche (Inst); Roche (Inst); Tesaro (Inst)
 
Manish Agrawal
No Relationships to Disclose
 
Michael S. Gordon
Stock and Other Ownership Interests - Caremission; WCCT Global
Consulting or Advisory Role - Castle Biosciences; Deciphera; RedHill Biopharma
Research Funding - Abbvie (Inst); Amgen (Inst); Amgen (Inst); Array BioPharma (Inst); Calithera Biosciences (Inst); Celldex (Inst); Deciphera (Inst); Endocyte (Inst); ESSA (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Lilly/ImClone (Inst); MedImmune (Inst); Merck Serono (Inst); Millennium (Inst); OncoMed (Inst); Pfizer (Inst); Plexxikon (Inst); Seagen (Inst); Sirtex Medical (Inst); Tokai Pharmaceuticals (Inst); TRACON Pharma (Inst)
 
Raid Aljumaily
No Relationships to Disclose
 
Carolyn D. Britten
Consulting or Advisory Role - Cleave Biosciences
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boston Biomedical (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Incyte (Inst); Keystone Nano (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); OncoMed (Inst); Pfizer (Inst); Plexxikon (Inst); RedHill Biopharma (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Five Prime Therapeutics
 
Luc Yves Dirix
No Relationships to Disclose
 
Keun-Wook Lee
Research Funding - AstraZeneca; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical
 
Matthew H. Taylor
Consulting or Advisory Role - Eisai; Onyx; PDX Pharmacy
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Eisai (Inst); Merck KGaA (Inst); Novartis (Inst)
 
Patrick Schöffski
Honoraria - Daiichi Sankyo; Eisai; Lilly; Medpace; Novartis; Swedish Orphan Biovitrum
Consulting or Advisory Role - Adaptimmune; Amcure; AstraZeneca; Bayer; Blueprint Medicines (Inst); Boehringer Ingelheim; Cristal Therapeutics; Daiichi Sankyo; Eisai; Epizyme; Genzyme; Ipsen; Lilly; Loxo; Medpace; Nektar; Novartis; Philogen; Piqur; Plexxikon
Speakers' Bureau - Bayer; Eisai; GlaxoSmithKline; Lilly; Novartis; PharmaMar; Swedish Orphan Biovitrum
Research Funding - Bayer; Blueprint Medicines; CoBioRes NV; Exelixis; GlaxoSmithKline; Novartis; Plexxikon
Travel, Accommodations, Expenses - Adaptimmune; Amcure; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Cristal Therapeutics; Daiichi Sankyo; Eisai; Epizyme; Genzyme; GlaxoSmithKline; Ipsen; Lilly; Loxo; Medpace; Nektar; Novartis; PharmaMar; Philogen; Piqur; Plexxikon; SI-Bone; Swedish Orphan Biovitrum
 
Ding Wang
No Relationships to Disclose
 
Alain Ravaud
No Relationships to Disclose
 
Arnold Gelb
Employment - EMD Serono
Stock and Other Ownership Interests - Halozyme
 
Junyuan Xiong
Employment - EMD Serono
 
Galit Rosen
Employment - EMD Serono
 
Manish R. Patel
No Relationships to Disclose